Search

everythinglearnresearchcommunity

for

Search:↓

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Letrozole may help prevent seizures by reducing certain hormone levels.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

PRP injections improve hair density in male hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Both microneedling and injections are equally effective for treating alopecia areata.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Baricitinib works better than methotrexate for severe alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Transdermal delivery using a fractional CO2 laser is more effective for treating alopecia areata than injections.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

PRP treatment increased hair density, especially in men and younger patients with AGA.

PRP is more effective than triamcinolone for treating alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.